Sara Vesely to Purpura, Thrombocytopenic, Idiopathic
This is a "connection" page, showing publications Sara Vesely has written about Purpura, Thrombocytopenic, Idiopathic.
Connection Strength
3.378
-
American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019 12 10; 3(23):3829-3866.
Score: 0.639
-
How can we provide the best care for our patients with immune thrombocytopenic pupura? Mayo Clin Proc. 2004 Apr; 79(4):456-7.
Score: 0.216
-
Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Ann Intern Med. 2004 Jan 20; 140(2):112-20.
Score: 0.213
-
Immune thrombocytopenic purpura--let the treatment fit the patient. N Engl J Med. 2003 Aug 28; 349(9):903-5.
Score: 0.207
-
Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol. 2003 Feb; 25(2):130-3.
Score: 0.199
-
Management of patients with chronic, refractory idiopathic thrombocytopenic purpura. Semin Hematol. 2000 Jul; 37(3):290-8.
Score: 0.166
-
Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists. J Pediatr Hematol Oncol. 2000 Jan-Feb; 22(1):55-61.
Score: 0.161
-
Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologists. J Thromb Thrombolysis. 2018 Jul; 46(1):24-30.
Score: 0.145
-
Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants. Pediatr Blood Cancer. 2018 Jan; 65(1).
Score: 0.136
-
Depression in adult patients with primary immune thrombocytopenia. Am J Hematol. 2016 10; 91(10):E462-3.
Score: 0.127
-
Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood. 2015 Jan 22; 125(4):616-8.
Score: 0.113
-
Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists. Am J Med Sci. 2014 Mar; 347(3):190-4.
Score: 0.107
-
Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS). Blood. 2013 May 30; 121(22):4457-62.
Score: 0.101
-
Conflicts of interest and clinical recommendations: comparison of two concurrent clinical practice guidelines for primary immune thrombocytopenia developed by different methods. Am J Med Qual. 2014 Jan-Feb; 29(1):53-60.
Score: 0.101
-
Determining a definite diagnosis of primary immune thrombocytopenia by medical record review. Am J Hematol. 2012 Sep; 87(9):843-7.
Score: 0.095
-
Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol. 2012 Sep; 87(9):848-52.
Score: 0.095
-
Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol. 2011 May; 86(5):420-9.
Score: 0.087
-
The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol. 2010 Mar; 85(3):174-80.
Score: 0.081
-
Addendum to corticosteroid side effects and risk for bleeding in immune thrombocytopenic purpura: patient perspectives. Eur J Haematol. 2009 Nov; 83(5):497-8.
Score: 0.078
-
Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol. 2009 Sep; 83(3):175-82.
Score: 0.076
-
Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood. 2008 Nov 15; 112(10):4003-8.
Score: 0.073
-
Is immune thrombocytopenic purpura less common among black Americans? Blood. 2005 Feb 01; 105(3):1368-9.
Score: 0.057
-
Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004 Nov 01; 104(9):2623-34.
Score: 0.055
-
Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care. Am J Hematol. 2003 Nov; 74(3):161-9.
Score: 0.052